4.7 Article

Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 96, 期 -, 页码 296-307

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2015.04.028

关键词

Trypanosoma cruzi; Leishmania mexicana; Plasmodium berghei; Quinazoline; Dihydrofolate reductase; Pteridin reductase

资金

  1. PAPIIT-UNAM [IN213914]
  2. SIT/COFAA-IPN
  3. [CONACYT-62488]

向作者/读者索取更多资源

In this paper, the design, synthesis and biological evaluation of a set of quinazoline-2,4,6-triamine derivatives (1-9) as trypanocidal, antileishmanial and antiplasmodial agents are explained. The compounds were rationalized basing on docking studies of the dihydrofolate reductase (DHFR from Trypanosoma cruzi, Leishmania major and Plasmodium vivax) and pteridin reductase (PTR from T. cruzi and L major) structures. All compounds were in vitro screened against both bloodstream trypomastigotes of T cruzi (NINOA and INC-5 strains) and prornatigotes of Leishmania mexicana (MHOM/BZ/61/M379 strain), and also for cytotoxicity using Vero cell line. Against T. cruzi, three compounds (5, 6 and 8) were the most effective showing a better activity profile than nifurtimox and benznidazole (reference drugs). Against L. mexicana, four compounds (5, 6, 8, and 9) exhibited the highest activity, even than glucantime (reference drug). In the cytotoxicity assay, protozoa were more susceptible than Vero cells. In vivo Plasmodium berghei assay (ANKA strain), the compounds 1, 5, 6 and 8 showed a more comparable activity than chloroquine and pyrimethamine (reference drugs) when they were administrated by the oral route. The antiprotozoal activity of these substances, endowed with redox properties, represented a good starting point for a medicinal chemistry program aiming for chemotherapy of Chagas' disease, leishmaniosis and malaria. (C) 2015 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Fucosterol from Sargassum horridum as an amyloid-beta (Aβ1-42) aggregation inhibitor: in vitro and in silico studies

Elena Sthephanie Castro-Silva, Martiniano Bello, Martha Cecilia Rosales-Hernandez, Jose Correa-Basurto, Maricarmen Hernandez-Rodriguez, Daniel Villalobos-Acosta, Juan Vicente Mendez-Mendez, Alan Estrada-Perez, Jesus Murillo-Alvarez, Mauricio Munoz-Ochoa

Summary: This study found that fucosterol extracted from an algal source has inhibitory effects on A beta(1-42) aggregation, which could potentially prevent the development of Alzheimer's disease.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Molecular modeling and LC-MS-based metabolomics of a glutamine-valproic acid (Gln-VPA) derivative on HeLa cells

M. J. Fragoso-Vazquez, D. Mendez-Luna, M. C. Rosales-Hernandez, G. R. Luna-Palencia, A. Estrada-Perez, Benedicte Fromager, I Vasquez-Moctezuma, J. Correa-Basurto

Summary: The study evaluated the hybrid compound Gln-VPA using various methods, showing its anti-proliferative effects and inhibition of glutaminase activity in HeLa cells. LC-MS metabolomics studies indicated that Gln-VPA and DON have different biological targets in the cell death mechanism.

MOLECULAR DIVERSITY (2021)

Article Biochemistry & Molecular Biology

Binding of Folate-G4-PAMAM dendrimer conjugate with indomethacin via ligand diffusion MD simulations

Alberto Martinez-Munoz, Jose Correa-Basurto, Martiniano Bello

Summary: In this study, the mechanism of how indomethacin forms complexes with folate-G4-PAMAM dendrimer was explored using ligand diffusion molecular dynamic simulations (LDMDSs) and molecular mechanics-generalized-born surface area (MMGBSA) approach. The results showed that the folate-G4-PAMAM dendrimer can bind indomethacin more effectively, indicating better encapsulation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Chemistry, Medicinal

Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells

David Mendez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamin Garcia-Vazquez, Martiniano Bello, Itzia Irene Padilla-Martinez, Manuel Jonathan Fragoso-Vazquez, Alfonso Duenas Gonzalez, Nuria De Pedro, Jose Antonio Gomez-Vidal, Humberto Lubriel Mendoza-Figueroa, Jose Correa-Basurto

Summary: The study designed and synthesized three new compounds with high affinity for the GPER binding site, which showed growth inhibitory activity in cancer cell lines without side effects. In silico studies revealed the binding modes and energetic features of the compounds on GPER, indicating potential for new compounds with growth inhibitory activities against nonconventional GPER cell models.

PHARMACEUTICALS (2021)

Article Multidisciplinary Sciences

Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population

Yudibeth Sixto-Lopez, Jose Correa-Basurto, Martiniano Bello, Bruno Landeros-Rivera, Jose Antonio Garzon-Tiznado, Sarita Montano

Summary: The SARS-CoV-2 virus has three lineages circulating worldwide, two of which have been found with three mutations among the Mexican population; these mutations significantly affect the structural behavior of the S protein and its binding with inhibitors; further experimental studies are needed to explore the clinical implications of these effects.

SCIENTIFIC REPORTS (2021)

Review Biochemistry & Molecular Biology

Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer's Disease Murine Models

Leticia Guadalupe Fragoso-Morales, Jose Correa-Basurto, Martha Cecilia Rosales-Hernandez

Summary: Alzheimer's disease is a major human dementia characterized by memory loss associated with oxidative stress in brain cells. Overexpression of NADPH oxidase in AD leads to the production of large amounts of reactive oxygen species, damaging brain cells and vasculature, making it a potential therapeutic target for AD.

ANTIOXIDANTS (2021)

Article Cell Biology

Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells

Yudibeth Sixto-Lopez, Emilie Marhuenda, Juan Benjamin Garcia-Vazquez, Manuel Jonathan Fragoso-Vazquez, Martha Cecilia Rosales-Hernandez, Oscar Zacarias-Lara, David Mendez-Luna, Jose Antonio Gomez-Vidal, David Cornu, Bakalara Norbert, Jose Correa-Basurto

Summary: Glioblastoma multiforme accounts for 70% of primary malignancies of the central nervous system, with a median survival after treatment of around 15 months. Research has identified HDAC inhibitors as showing antiproliferative properties in 3D cultures, suggesting they may be a key target for future therapeutic studies.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [d] [1,3] Azoles

Ozvaldo Linares-Anaya, Alcives Avila-Sorrosa, Francisco Diaz-Cedillo, Luis Angel Gil-Ruiz, Jose Correa-Basurto, Domingo Salazar-Mendoza, Adrian L. Orjuela, Jorge Ali-Torres, Maria Teresa Ramirez-Apan, David Morales-Morales

Summary: Two benzo[d][1,3]azoles 2-substituted with benzyl- and allyl-sulfanyl groups, BTA-1 and BMZ-2, showed promising cytotoxic activities against six human cancer cell lines in vitro. BMZ-2 exhibited comparable inhibitory effects to tamoxifen in some cases and displayed low cytotoxicity against healthy cells. Computational molecular docking studies revealed the affinity and possible interactions of both compounds with the tamoxifen binding site on ER alpha and GPER receptors.

MOLECULES (2021)

Article Multidisciplinary Sciences

Chemical characterization (LC-MS-ESI), cytotoxic activity and intracellular localization of PAMAM G4 in leukemia cells

R. Flores-Mejia, M. J. Fragoso-Vazquez, L. G. Perez-Blas, A. Parra-Barrera, S. S. Hernandez-Castro, A. R. Estrada-Perez, J. Rodrigues, E. Lara-Padilla, A. Ortiz-Morales, J. Correa-Basurto

Summary: The study investigates the chemical structure, cytotoxicity, and antiproliferative effects of G4-PAMAM, as well as its intracellular localization in the HMC-1 and K-562 cell lines. The results show that G4-PAMAM generates multivalent mass spectrum values and exhibits antiproliferative activity in both tumor cell lines. Additionally, the dendrimers were found in the cytoplasm and nucleus of the studied tumor cells.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Medicinal

In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease

Ulises Martinez-Ortega, Diego Figueroa-Figueroa, Francisco Hernandez-Luis, Rodrigo Aguayo-Ortiz

Summary: This study conducted molecular dynamics simulations of the interaction between masitinib (MST) and SARS-CoV-2 main protease (M-pro), identifying factors influencing the stability of the complex and providing valuable insights for the design of new MST analogs as potential treatments for COVID-19.

CHEMMEDCHEM (2021)

Article Chemistry, Medicinal

Myeloperoxidase Inhibitory and Antioxidant Activities of (E)-2-Hydroxy-α-aminocinnamic Acids Obtained through Microwave-Assisted Synthesis

Astrid Rivera-Antonio, Martha Cecilia Rosales-Hernandez, Irving Balbuena-Rebolledo, Jose Martin Santiago-Quintana, Jessica Elena Mendieta-Wejebe, Jose Correa-Basurto, Juan Benjamin Garcia-Vazquez, Efren Venancio Garcia-Baez, Itzia I. Padilla-Martinez

Summary: A novel synthesis method for (E)-2-hydroxy-alpha-aminocinnamic acids was reported, demonstrating their antioxidant properties and ability to scavenge free radicals, inhibit MPO, with low cytotoxicity. The compounds show promising potential for further exploration as therapeutic agents for chronic diseases related to MPO activity.

PHARMACEUTICALS (2021)

Article Chemistry, Multidisciplinary

Enhancing the antidiabetic and antidyslipidemic activity of a 1,5-diarylpyrazole by solid dispersion pre-formulation

Eduardo Hernandez-Vazquez, Samuel Estrada-Soto, Norma Lumbreras-Zavala, Martin Mundo-Campuzano, Fabiola Chavez-Silva, Rafael Villalobos-Molina, Francisco Hernandez-Luis

Summary: Pre-formulating 1,5-diarylpyrazoles with polyvinylpyrrolidone enhances their antidiabetic activity and improves lipidic profile and antidyslipidemic properties. Pre-formulation also enhances the antihyperglycemic activity of the dehalogenated pyrazole without causing hypoglycemia.

CHEMICAL PAPERS (2022)

Article Chemistry, Medicinal

Synthesis of Quinazolin-2,4,6-triamine Derivatives as Non-purine Xanthine Oxidase Inhibitors and Exploration of Their Toxicological Potential

Marcela A. Lopez-Sanchez, Maria del Carmen Garcia-Rodriguez, Rodrigo Aguayo-Ortiz, Estefani Hernandez-Cruz, Diego I. Figueroa-Figueroa, Francisco Hernandez-Luis

Summary: In this study, a new series of quinazolin-2,4,6-triamine derivatives were synthesized and evaluated for their potential biological activities as xanthine oxidase inhibitors, superoxide scavengers, and toxicological profile screening. Among the synthesized compounds, B1 showed better inhibitory activity against bovine xanthine oxidase compared to allopurinol. Furthermore, B1, B2, and B13 exhibited superior superoxide scavenging effects compared to allopurinol. In terms of cytotoxicity, B1 was found to be less toxic than methotrexate on HCT15 cancer cells. Apoptosis studies on mice cells showed that B1 and B2 had similar effects to CrO3 in inducing apoptosis, while the effect of B13 was similar to DMSO and the control group. Lastly, B1, B2, and B13 did not induce genotoxicity in a micronuclei murine model when compared to CrO3.

CHEMMEDCHEM (2023)

Article Chemistry, Multidisciplinary

Energetics of a protein disorder-order transition in small molecule recognition

Cesar Mendoza-Martinez, Michail Papadourakis, Salome Llabres, Arun A. Gupta, Paul N. Barlow, Julien Michel

Summary: In this study, the selectivity of a drug-like small molecule in modulating the disorder-to-order transition of a protein is investigated. The results show that the molecule induces order in a specific region of the protein, shifting the balance of the protein complex. This research is of significance in targeting intrinsically disordered regions in medicinal chemistry.

CHEMICAL SCIENCE (2022)

Review Medicine, General & Internal

Breastfeeding and COVID-19

Norma Del C. Galindo-Sevilla, Nilson A. Contreras-Carreto, Araceli Rojas-Bernabe, Javier Mancilla-Ramirez

Summary: The COVID-19 pandemic has raised concerns among mothers and breastfeeding women about the possible transmission of the virus through breast milk. However, there is no evidence of vertical transmission, and the risk of horizontal transmission to infants is similar to the general population. Breastfeeding may even have a beneficial effect on the clinical course of COVID-19 in newborns.

GACETA MEDICA DE MEXICO (2021)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)